Use of phanquinone for the treatment of Alzheimer's disease

Details Use of phanquinone for the treatment of Alzheimer's disease Use of phanquinone for the treatment of Alzheimer's disease

2003-11-18

2009-12-08

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S284000, C514S290000, C514S474000, C514S458000, C514S682000

Reexamination Certificate

active

07629354

ABSTRACT:
The use of phanquinone for the manufacture of a pharmaceutical composition for the prevention or the treatment of Alzheimer's disease is disclosed. Also methods of treatment or prevention of Alzheimer's disease are disclosed.

REFERENCES:
patent: 3574819 (1971-04-01), Gross
patent: 3651205 (1972-03-01), Hunger et al.
patent: 4981844 (1991-01-01), Alexander et al.
patent: 5091391 (1992-02-01), Aizenman et al.
patent: 5545670 (1996-08-01), Bissbort et al.
patent: 5561164 (1996-10-01), Gutteridge et al.
patent: 5656286 (1997-08-01), Miranda et al.
patent: 5719197 (1998-02-01), Kanios et al.
patent: 5980882 (1999-11-01), Eichman
patent: 5980914 (1999-11-01), Gerolymatos
patent: 5994323 (1999-11-01), Gerolymatos
patent: 6001852 (1999-12-01), Gerolymatos
patent: 6165500 (2000-12-01), Ceve
patent: 6221383 (2001-04-01), Miranda et al.
patent: 2003/0055078 (2003-03-01), Xilinas et al.
patent: 40311 (1975-04-01), None
patent: WO 9531199 (1995-11-01), None
patent: WO 00/40244 (2000-07-01), None
patent: WO 01/82911 (2001-11-01), None
patent: WO 01/82912 (2001-11-01), None
Kendar NP, “Can we prevent Parkinson's and Alzheimer's disease?” J Postgrad Med, 2003, vol. 49, pp. 236-245, see abstract.
WHO “Persistent Diarrhoea” Indian J Pediatrics, 1989, vol. 56, pp. 545-548.
Chaiyabutr N. et al. Urinary Bladder Effects After Oral Dosages of the Antidiarrhoeal Drug (Clioquinol/Phanquinone/Oxyphenonium Bromide) in Experimental Dogs. J Med Ass Thailand. Dec. 1985; 68(12):649-53.
Bauer A.G. et al. Failure of Conventional Treatment to Prevent Relapse of Hepatic Amoebiasis. Neth J Med. 1981; 24(1):6-9.
Yadava J.N. et al. Combined Action of Antiamoebic Drugs and Antibiotics on Axenically Grown Entamoeba Histolytica. Indian J Med Res. Jul. 1973; 61(7):971-5.
Konzert W. [Experiences with a new combination preparation—iodochlorhydroxyquin (V ioform)+4,7-phenantroline-5,6-quinone (Entobex) in the treatment of anti-infectious dyspepsia in infants and small children] Wien Med Wochenschr. Nov 6, 1971; 121(45):808-11 [in German with English translation].
Jarzebinski J. et al. Pharmaceutical Preparations Containing Quaternary Ammonium Salts. Acta Pol Pharm. 1988; vol. 45, issue: 4, p. 324-328 [in Polish with English summary].
de Graaff C.S. et al. A Patient With Opportunistic Infections Due to Acquired Immunodeficiency Syndrome. Ned Tijdschr Geneeskd. Mar. 24, 1984; 128(12):549-53 [in Dutch with English summary].
Ruggiero G. et al. Chronic Intestinal Amoebiasis: A case report. G. Mal. Infett. Parassit. (Italy) 1980, 32/5 (360-363) [in Italian with English summary].

Affiliated with

Also associated with

Rating

Use of phanquinone for the treatment of Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of phanquinone for the treatment of Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of phanquinone for the treatment of Alzheimer's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4075929